Co-Diagnostics (NASDAQ:CODX) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Co-Diagnostics beat estimated earnings by 100.0%, reporting an EPS of $0.34 versus an estimate of $0.17.
Revenue was up $2.67 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.13 which was followed by a 11.6% drop in the share price the next day.
Here's a look at Co-Diagnostics's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.12 | 0.21 | 0.22 | 0.22 |
| EPS Actual | 0.25 | 0.38 | 0.33 | 0.26 |
| Revenue Estimate | 20.93M | 24.32M | 20.77M | 19.89M |
| Revenue Actual | 20.40M | 30.10M | 27.36M | 20.02M |
To track all earnings releases for Co-Diagnostics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
